0

Journal Articles

in Health Policy/Health Economics
 181-200 of 890 Articles
From the Centers for Disease Control and Prevention |  FREE
JAMA. 2012;307(7):661. doi:.

Capitol Health Call | 
Mike Mitka
JAMA. 2012;307(6):553. doi:10.1001/jama.2012.92.

Viewpoint | 
Allan S. Detsky, MD, PhD; Stephen R. Gauthier, BSc; Victor R. Fuchs, PhD
JAMA. 2012;307(5):463-464. doi:10.1001/jama.2012.44.

Viewpoint | 
Shantanu Agrawal, MD; Peter Budetti, MD, JD
JAMA. 2012;307(5):459-460. doi:10.1001/jama.2012.78.

Viewpoint | 
Lawrence O. Gostin, JD; Kelli K. Garcia, JD, PhD
JAMA. 2012;307(4):369-370. doi:10.1001/jama.2012.16.

From the Centers for Disease Control and Prevention |  FREE
JAMA. 2012;307(4):358. doi:.

Capitol Health Call | 
Mike Mitka
JAMA. 2012;307(2):134. doi:10.1001/jama.2011.1928.

Viewpoint | 
Barbara K. Gehrett, MD
JAMA. 2012;307(2):153-154. doi:10.1001/jama.2011.2000.

Viewpoint | 
Allan S. Brett, MD; Laurence B. McCullough, PhD
JAMA. 2012;307(2):149-150. doi:10.1001/jama.2011.1999.

Viewpoint | 
Ezekiel J. Emanuel, MD, PhD
JAMA. 2012;307(1):39-40. doi:10.1001/jama.2011.1927.

Viewpoint | 
Jonathan S. Skinner, PhD; James N. Weinstein, DO, MS; Elliott S. Fisher, MD, MPH
JAMA. 2012;307(1):43-44. doi:10.1001/jama.2011.1946.

Viewpoint | 
Robert H. Brook, MD, ScD
JAMA. 2012;307(1):41-42. doi:10.1001/jama.2011.1948.

Editorial | 
Howard Bauchner, MD; Phil B. Fontanarosa, MD, MBA
JAMA. 2012;307(1):90-91. doi:10.1001/jama.2011.1958.

Capitol Health Call | 
Mike Mitka
JAMA. 2011;306(22):2443. doi:10.1001/jama.2011.1764.

Capitol Health Call | 
Mike Mitka
JAMA. 2011;306(22):2443. doi:10.1001/jama.2011.1766.

Commentary | 
Allan S. Detsky, MD, PhD
JAMA. 2011;306(22):2500-2501. doi:10.1001/jama.2011.1819.

Commentary | 
Patrick H. Conway, MD, MSc; Donald M. Berwick, MD, MPP
JAMA. 2011;306(20):2256-2257. doi:10.1001/jama.2011.1611.

Capitol Health Call | 
Mike Mitka
JAMA. 2011;306(18):1970. doi:10.1001/jama.2011.1600.

Commentary | 
Robert H. Brook, MD, ScD
JAMA. 2011;306(18):2020-2021. doi:10.1001/jama.2011.1621.

Commentary | 
Franklin G. Miller, PhD; Steven D. Pearson, MD, MSc
JAMA. 2011;306(18):2024-2025. doi:10.1001/jama.2011.1631.

Sign In

Register for a FREE personal account

and access these and other features:

Register Now

Want to Subscribe?

Learn More about subscription options.

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

From The JAMA Network
JAMA Internal Medicine
Original Investigation  | 
Cost Consideration in the Clinical Guidance Documents of Physician Specialty Societies in the United States
Jennifer A. T. Schwartz, MD; Steven D. Pearson, MD, MSc
JAMA Internal Medicine
Original Investigation  | 
Cognition and Take-up of Subsidized Drug Benefits by Medicare Beneficiaries
Ifedayo O. Kuye, AB; Richard G. Frank, PhD; J. Michael McWilliams, MD, PhD
JAMA Internal Medicine
Invited Commentary  | 
Supporting High-Value Part D Medicare Choices for Low-Income Beneficiaries:  Comment on “Cognition and Take-up of Subsidized Drug Benefits by Medicare Beneficiaries”
Karen L. Margolis, MD, MPH
JAMA Internal Medicine
Viewpoint  | 
Coverage With Evidence Development for Medicare Beneficiaries:  Challenges and Next Steps
Gregory W. Daniel, PhD, MPH; Erin K. Rubens, MPH, MBA; Mark McClellan, MD, PhD